News
ATR
129.11
+0.65%
0.83
AptarGroup price target raised to $160 from $150 at Raymond James
TipRanks · 19h ago
BofA shakes up packaging and paper ratings with upgrade, four downgrades
TipRanks · 1d ago
AptarGroup upgraded to Buy from Neutral at BofA
TipRanks · 1d ago
Weekly Report: what happened at ATR last week (0706-0710)?
Weekly Report · 2d ago
Is AptarGroup (ATR) Undervalued On Its Revised Fair Value And Revenue Growth Outlook?
Simply Wall St · 5d ago
Notable Two Hundred Day Moving Average Cross - ATR
NASDAQ · 07/08 21:21
Weekly Report: what happened at ATR last week (0629-0703)?
Weekly Report · 07/06 09:04
AptarGroup Has Fallen Enough (Rating Upgrade)
Seeking Alpha · 06/29 09:41
Weekly Report: what happened at ATR last week (0622-0626)?
Weekly Report · 06/29 09:03
10 mid-cap U.S. materials stocks with the weakest momentum grades
Seeking Alpha · 06/24 15:05
Weekly Report: what happened at ATR last week (0615-0619)?
Weekly Report · 06/22 09:04
AptarGroup (ATR) Stock Could Be 25.5% Undervalued on Its Drug Delivery Growth Narrative
Simply Wall St · 06/18 23:45
Aptar Releases 2025 Corporate Sustainability Report
Barchart · 06/18 16:00
Weekly Report: what happened at ATR last week (0608-0612)?
Weekly Report · 06/15 09:04
Is West Pharmaceutical Stock Outperforming the S&P 500?
Barchart · 06/15 01:55
Top AptarGroup Executive Makes Bold Insider Move
TipRanks · 06/11 02:09
AptarGroup (ATR) Valuation In Focus As Market Weighs Growth Investments Against Legal Costs And Softer Demand
Simply Wall St · 06/10 18:21
Weekly Report: what happened at ATR last week (0601-0605)?
Weekly Report · 06/08 09:04
Top AptarGroup Executive Makes Notable Insider Move With Major Stock Sale
TipRanks · 06/06 02:04
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year
Barchart · 06/02 16:00
More
Webull provides a variety of real-time ATR stock news. You can receive the latest news about Aptargroup through multiple platforms. This information may help you make smarter investment decisions.
About ATR
AptarGroup, Inc. is engaged in the design and manufacturing of drug and consumer product dosing, dispensing, and protection technologies. The Company serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. It also manufactures and sells elastomeric primary packaging components. It operates through three segments, which include the Pharma segment, Beauty segment, and Closures segment. The Pharma segment is a supplier of nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and health care markets worldwide. The Beauty segment sells pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care, and home care markets. The Closures segment includes dispensing and non-dispensing solutions that enable product delivery without removal of the cap and are used across multiple consumer end markets.